International Journal of Molecular Sciences (Sep 2022)

Stem Cell Therapy for Sequestration of Traumatic Brain Injury-Induced Inflammation

  • Mia C. Borlongan,
  • Susanna Rosi

DOI
https://doi.org/10.3390/ijms231810286
Journal volume & issue
Vol. 23, no. 18
p. 10286

Abstract

Read online

Traumatic brain injury (TBI) is one of the leading causes of long-term neurological disabilities in the world. TBI is a signature disease for soldiers and veterans, but also affects civilians, including adults and children. Following TBI, the brain resident and immune cells turn into a “reactive” state, characterized by the production of inflammatory mediators that contribute to the development of cognitive deficits. Other injuries to the brain, including radiation exposure, may trigger TBI-like pathology, characterized by inflammation. Currently there are no treatments to prevent or reverse the deleterious consequences of brain trauma. The recognition that TBI predisposes stem cell alterations suggests that stem cell-based therapies stand as a potential treatment for TBI. Here, we discuss the inflamed brain after TBI and radiation injury. We further review the status of stem cells in the inflamed brain and the applications of cell therapy in sequestering inflammation in TBI.

Keywords